Before revision:  The applicability of this approach is further demonstrated by applying it to both publically available microarray data from multiple sclerosis and diabetes patients as well as RNA sequencing data from breast cancer patients . Our method confers more global, physiologically relevant, knowledge about the datasets than traditional and more myopic methods .
After revision:  The applicability of this approach is further demonstrated by applying it to both publically available microarray data from multiple sclerosis and diabetes patients as well as RNA sequencing data from breast cancer patients .